ポイント・オブ・ケア(POC)分析装置:医療機器パイプライン分析2017

◆英語タイトル:Point-of-Care (POC) Analyzers - Medical Devices Pipeline Assessment, 2017
◆商品コード:GDME0433EPD
◆発行会社(リサーチ会社):GlobalData
◆発行日:2017年9月8日
◆ページ数:130
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD4,000 ⇒換算¥444,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD8,000 ⇒換算¥888,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD12,000 ⇒換算¥1,332,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Point-of-Care (POC) Analyzers – Medical Devices Pipeline Assessment, 2017
Summary

GlobalData’s Medical Devices sector report, “Point-of-Care (POC) Analyzers – Medical Devices Pipeline Assessment, 2017″ provides an overview of Point-of-Care (POC) Analyzers currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Point-of-Care (POC) Analyzers pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Point-of-Care (POC) Analyzers under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Point-of-Care (POC) Analyzers and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Point-of-Care (POC) Analyzers under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 9
2 Introduction 10
2.1 Point-of-Care (POC) Analyzers Overview 10
3 Products under Development 11
3.1 Point-of-Care (POC) Analyzers – Pipeline Products by Stage of Development 11
3.2 Point-of-Care (POC) Analyzers – Pipeline Products by Territory 12
3.3 Point-of-Care (POC) Analyzers – Pipeline Products by Regulatory Path 13
3.4 Point-of-Care (POC) Analyzers – Pipeline Products by Estimated Approval Date 14
3.5 Point-of-Care (POC) Analyzers – Ongoing Clinical Trials 15
4 Point-of-Care (POC) Analyzers – Pipeline Products under Development by Companies 16
4.1 Point-of-Care (POC) Analyzers Companies – Pipeline Products by Stage of Development 16
4.2 Point-of-Care (POC) Analyzers – Pipeline Products by Stage of Development 18
5 Point-of-Care (POC) Analyzers Companies and Product Overview 20
5.1 Akers Biosciences Inc Company Overview 20
5.1.1 Akers Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 20
5.2 Akonni Biosystems Inc Company Overview 22
5.2.1 Akonni Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview 22
5.3 Alere Inc Company Overview 23
5.3.1 Alere Inc Pipeline Products & Ongoing Clinical Trials Overview 23
5.4 Amplino B.V. Company Overview 24
5.4.1 Amplino B.V. Pipeline Products & Ongoing Clinical Trials Overview 24
5.5 Analytical Diagnostic Solutions Inc Company Overview 25
5.5.1 Analytical Diagnostic Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 25
5.6 ApoCell Inc Company Overview 26
5.6.1 ApoCell Inc Pipeline Products & Ongoing Clinical Trials Overview 26
5.7 Aquila Diagnostic Systems Inc. Company Overview 27
5.7.1 Aquila Diagnostic Systems Inc. Pipeline Products & Ongoing Clinical Trials Overview 27
5.8 Atonomics A/S Company Overview 28
5.8.1 Atonomics A/S Pipeline Products & Ongoing Clinical Trials Overview 28
5.9 Attophotonics Biosciences GmbH Company Overview 29
5.9.1 Attophotonics Biosciences GmbH Pipeline Products & Ongoing Clinical Trials Overview 29
5.10 Beckman Coulter Inc Company Overview 30
5.10.1 Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 30
5.11 Binghamton University Company Overview 31
5.11.1 Binghamton University Pipeline Products & Ongoing Clinical Trials Overview 31
5.12 Bio-Alternative Medical Devices Ltd Company Overview 32
5.12.1 Bio-Alternative Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview 32
5.13 BioMedomics Inc Company Overview 33
5.13.1 BioMedomics Inc Pipeline Products & Ongoing Clinical Trials Overview 33
5.14 bioMerieux S.A. Company Overview 35
5.14.1 bioMerieux S.A. Pipeline Products & Ongoing Clinical Trials Overview 35
5.15 Biopico Systems Inc. Company Overview 36
5.15.1 Biopico Systems Inc. Pipeline Products & Ongoing Clinical Trials Overview 36
5.16 Boston University Company Overview 37
5.16.1 Boston University Pipeline Products & Ongoing Clinical Trials Overview 37
5.17 CardioGenics Inc Company Overview 39
5.17.1 CardioGenics Inc Pipeline Products & Ongoing Clinical Trials Overview 39
5.18 Cepheid Company Overview 40
5.18.1 Cepheid Pipeline Products & Ongoing Clinical Trials Overview 40
5.19 ChipCare Corp Company Overview 44
5.19.1 ChipCare Corp Pipeline Products & Ongoing Clinical Trials Overview 44
5.20 City, University of London Company Overview 45
5.20.1 City, University of London Pipeline Products & Ongoing Clinical Trials Overview 45
5.21 Co-Diagnostics HBDC, Inc. Company Overview 46
5.21.1 Co-Diagnostics HBDC, Inc. Pipeline Products & Ongoing Clinical Trials Overview 46
5.22 Exosome Diagnostics Inc Company Overview 47
5.22.1 Exosome Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 47
5.23 Florida International University Company Overview 48
5.23.1 Florida International University Pipeline Products & Ongoing Clinical Trials Overview 48
5.24 Indian Institute of Technology Madras Company Overview 49
5.24.1 Indian Institute of Technology Madras Pipeline Products & Ongoing Clinical Trials Overview 49
5.25 Indiana University Company Overview 50
5.25.1 Indiana University Pipeline Products & Ongoing Clinical Trials Overview 50
5.26 Magna Diagnostics GmbH Company Overview 51
5.26.1 Magna Diagnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview 51
5.27 Maxygen-mobile DNA tests Company Overview 52
5.27.1 Maxygen-mobile DNA tests Pipeline Products & Ongoing Clinical Trials Overview 52
5.28 mBio Diagnostics Inc Company Overview 53
5.28.1 mBio Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 53
5.29 McKesson Corp Company Overview 54
5.29.1 McKesson Corp Pipeline Products & Ongoing Clinical Trials Overview 54
5.30 MML Ltd Company Overview 55
5.30.1 MML Ltd Pipeline Products & Ongoing Clinical Trials Overview 55
5.31 Molbio Diagnostics Pvt. Ltd. Company Overview 56
5.31.1 Molbio Diagnostics Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 56
5.32 Molecular Warehouse Ltd Company Overview 57
5.32.1 Molecular Warehouse Ltd Pipeline Products & Ongoing Clinical Trials Overview 57
5.33 Mologic Ltd Company Overview 58
5.33.1 Mologic Ltd Pipeline Products & Ongoing Clinical Trials Overview 58
5.34 Nalia Systems Ltd Company Overview 59
5.34.1 Nalia Systems Ltd Pipeline Products & Ongoing Clinical Trials Overview 59
5.35 Newcastle University Company Overview 60
5.35.1 Newcastle University Pipeline Products & Ongoing Clinical Trials Overview 60
5.36 Ohmx Corp Company Overview 61
5.36.1 Ohmx Corp Pipeline Products & Ongoing Clinical Trials Overview 61
5.37 OncoGenesis Company Overview 62
5.37.1 OncoGenesis Pipeline Products & Ongoing Clinical Trials Overview 62
5.38 Pacific Nanoscience, Inc. Company Overview 63
5.38.1 Pacific Nanoscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview 63
5.39 Parallax Health Sciences, Inc. Company Overview 64
5.39.1 Parallax Health Sciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 64
5.40 Phoenix Biosystems Inc Company Overview 65
5.40.1 Phoenix Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview 65
5.41 POC Medical Systems Inc. Company Overview 66
5.41.1 POC Medical Systems Inc. Pipeline Products & Ongoing Clinical Trials Overview 66
5.42 Pocared Diagnostics Ltd. Company Overview 67
5.42.1 Pocared Diagnostics Ltd. Pipeline Products & Ongoing Clinical Trials Overview 67
5.43 PositiveID Corp Company Overview 68
5.43.1 PositiveID Corp Pipeline Products & Ongoing Clinical Trials Overview 68
5.44 Quanterix Corp Company Overview 70
5.44.1 Quanterix Corp Pipeline Products & Ongoing Clinical Trials Overview 70
5.45 Radisens Diagnostics Ltd Company Overview 71
5.45.1 Radisens Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 71
5.46 SenGenix Inc Company Overview 72
5.46.1 SenGenix Inc Pipeline Products & Ongoing Clinical Trials Overview 72
5.47 Thermal Gradient Inc Company Overview 73
5.47.1 Thermal Gradient Inc Pipeline Products & Ongoing Clinical Trials Overview 73
5.48 Trinity Biotech Plc Company Overview 75
5.48.1 Trinity Biotech Plc Pipeline Products & Ongoing Clinical Trials Overview 75
5.49 Two Pore Guys Inc Company Overview 76
5.49.1 Two Pore Guys Inc Pipeline Products & Ongoing Clinical Trials Overview 76
5.50 University of California Berkeley Company Overview 77
5.50.1 University of California Berkeley Pipeline Products & Ongoing Clinical Trials Overview 77
5.51 ViroCyt Inc Company Overview 80
5.51.1 ViroCyt Inc Pipeline Products & Ongoing Clinical Trials Overview 80
5.52 Wellstat Diagnostics LLC Company Overview 81
5.52.1 Wellstat Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 81
6 Point-of-Care (POC) Analyzers- Recent Developments 82
6.1 Aug 30, 2017: PositiveID’s ExcitePCR Subsidiary Announces FireflyDX-Portable: A Lightweight, Bookbag-sized, Realtime Pathogen Detection System, with Commercial Availability Slated for Summer 2018 82
6.2 Aug 30, 2017: bioMerieux – First-Half 2017 Results 83
6.3 Aug 16, 2017: Two Pore Guys Announces Positive Results from Pilot Point-of-Care Liquid Biopsy Study with UCSF 86
6.4 Aug 08, 2017: PositiveID Successfully Detects Ebola Virus on its Firefly Dx Prototype System 87
6.5 Jul 27, 2017: McKesson Reports Fiscal 2018 First-Quarter Results 88
6.6 Jul 20, 2017: bioMerieux – Second-Quarter 2017 Business Review 89
6.7 Jul 18, 2017: Quanterix Boosts Investments in its Accelerator Lab to Support Rapid Growth of Simoa Technology 92
6.8 Jul 18, 2017: Quanterix, Partners Develop PCR-free miRNA Detection Method for Liver Toxicity Testing 93
6.9 Jun 21, 2017: Diabetes Research Unit Cymru confirms EKF POCT HbA1c testing comparable to lab-based HPLC 94
6.10 Jun 15, 2017: Zenosense: Issuance of U.S. MIDS Patent 94
6.11 May 31, 2017: Exosome Diagnostics Will Demonstrate the “Shahky” Point of Care Protein Detection Instrument at American Society for Clinical Oncology 95
6.12 May 24, 2017: PositiveID Forms ExcitePCR Subsidiary to Better Position its Firefly Dx System for $19 Billion Global Point-of-Care Diagnostics Market 96
6.13 May 18, 2017: McKesson Reports Fiscal 2017 Fourth-Quarter and Full-Year Results 96
6.14 Apr 20, 2017: bioMerieux – First-Quarter 2017 Business Review 99
6.15 Mar 02, 2017: McKesson Provides Financial Update to Reflect Creation of a New Healthcare Information Technology Company 102
6.16 Feb 16, 2017: New study reaffirms Quo-Test A1c meets IFCC performance criteria 103
6.17 Feb 03, 2017: Exosome Diagnostics Announces Early Access Program for “Shahky” – Exosome Protein Interrogation Instrument 104
6.18 Jan 26, 2017: Vantage Oncology’s 50 Centers and More Than 350 Affiliated Physicians Join The US Oncology Network 105
6.19 Jan 25, 2017: McKesson Reports Fiscal 2017 Third-Quarter Results 106
6.20 Jan 23, 2017: Zenosense: New Patent Application for Additional MIDS Detection Method 108
6.21 Jan 19, 2017: bioMerieux – Fourth-Quarter 2016 Business Review 109
6.22 Jan 17, 2017: McKesson Finalizes Settlement with U.S. Department of Justice and U.S. Drug Enforcement Administration to Resolve Past Claims 112
6.23 Jan 11, 2017: GenePOC Announces CE Marking for its Revogene Instrument 113
6.24 Jan 05, 2017: McKesson and Change Healthcare Announce New Company Will Be Named Change Healthcare 113
6.25 Jan 04, 2017: Exosome Diagnostics Runs World’s First Point of Care Liquid Biopsy Instrument Within Leading Boston Hospital 114
6.26 Dec 28, 2016: McKesson Completes Acquisition of Rexall Health and Appoints Domenic Pilla as CEO of McKesson Canada 115
6.27 Dec 21, 2016: McKesson and Change Healthcare Announce Termination off Hart-Scott-Rodino Act Waiting Period for the Creation of a New Healthcare Information Technology Company 116
6.28 Dec 08, 2016: Exosome Diagnostics Announces the First Instrument for Point of Care Liquid Biopsy 116
6.29 Nov 29, 2016: Beckman Coulter announces significant investment in UK microbiology market with DxN VERIS Molecular Diagnostics System 117
6.30 Nov 15, 2016: PositiveID to Exhibit Firefly Dx System at the AMSUS Federal Health 2016 Conference 117
6.31 Nov 07, 2016: Pierre Boulud appointed Corporate Vice Presidentof the Asia Pacific region at bioMerieux 117
6.32 Oct 31, 2016: Zenosense MIDS Cardiac Bench Reader Development 118
6.33 Oct 27, 2016: McKesson Reports Fiscal 2017 Second-Quarter Results and Revised Fiscal 2017 Outlook 118
6.34 Oct 24, 2016: McKesson Releases Fiscal 2016 Corporate Social Responsibility Report 120
6.35 Oct 20, 2016: ViroCyt Develops Rapid Detection System For Enterovirus 71 121
6.36 Oct 20, 2016: bioMerieux-Business Review for the nine months ended September 30, 2016 122
6.37 Oct 04, 2016: Trinity Biotech Announces FDA 510(k) Submission withdrawal for Meritas Point of Care Analyzer 124
6.38 Sep 19, 2016: Zenosense General Update – Cardiac Device Development 125
7 Appendix 127
7.1 Methodology 127
7.2 About GlobalData 130
7.3 Contact Us 130
7.4 Disclaimer 130

1.1 List of Tables
Table 1: Point-of-Care (POC) Analyzers - Pipeline Products by Stage of Development 11
Table 2: Point-of-Care (POC) Analyzers - Pipeline Products by Territory 12
Table 3: Point-of-Care (POC) Analyzers - Pipeline Products by Regulatory Path 13
Table 4: Point-of-Care (POC) Analyzers - Pipeline Products by Estimated Approval Date 14
Table 5: Point-of-Care (POC) Analyzers - Ongoing Clinical Trials 15
Table 6: Point-of-Care (POC) Analyzers Companies - Pipeline Products by Stage of Development 16
Table 7: Point-of-Care (POC) Analyzers - Pipeline Products by Stage of Development 18
Table 8: Akers Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 20
Table 9: minDNAnalyzer - Product Status 20
Table 10: minDNAnalyzer - Product Description 21
Table 11: Akonni Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview 22
Table 12: TruDx 2000 Platform - Product Status 22
Table 13: TruDx 2000 Platform - Product Description 22
Table 14: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview 23
Table 15: Clondiag HIV Molecular Device - Product Status 23
Table 16: Clondiag HIV Molecular Device - Product Description 23
Table 17: Amplino B.V. Pipeline Products & Ongoing Clinical Trials Overview 24
Table 18: Scout PCR Analyzer - Product Status 24
Table 19: Scout PCR Analyzer - Product Description 24
Table 20: Analytical Diagnostic Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 25
Table 21: POC Device - Malaria - Product Status 25
Table 22: POC Device - Malaria - Product Description 25
Table 23: ApoCell Inc Pipeline Products & Ongoing Clinical Trials Overview 26
Table 24: ApoStream System - Product Status 26
Table 25: ApoStream System - Product Description 26
Table 26: Aquila Diagnostic Systems Inc. Pipeline Products & Ongoing Clinical Trials Overview 27
Table 27: Accutas Malaria Diagnostic System - Product Status 27
Table 28: Accutas Malaria Diagnostic System - Product Description 27
Table 29: Atonomics A/S Pipeline Products & Ongoing Clinical Trials Overview 28
Table 30: Atolyzer PoC - Product Status 28
Table 31: Atolyzer PoC - Product Description 28
Table 32: Attophotonics Biosciences GmbH Pipeline Products & Ongoing Clinical Trials Overview 29
Table 33: Nanoparticle Microfluidic Color Device - Product Status 29
Table 34: Nanoparticle Microfluidic Color Device - Product Description 29
Table 35: Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 30
Table 36: DxN VERIS MDx System - Product Status 30
Table 37: DxN VERIS MDx System - Product Description 30
Table 38: Binghamton University Pipeline Products & Ongoing Clinical Trials Overview 31
Table 39: U-PAC - Product Status 31
Table 40: U-PAC - Product Description 31
Table 41: Bio-Alternative Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview 32
Table 42: Magnetic Immunoassay Detection System - Product Status 32
Table 43: Magnetic Immunoassay Detection System - Product Description 32
Table 44: BioMedomics Inc Pipeline Products & Ongoing Clinical Trials Overview 33
Table 45: Next Generation Ultra-sensitive Nanotube Platform - Product Status 33
Table 46: Next Generation Ultra-sensitive Nanotube Platform - Product Description 33
Table 47: TR-LFIA Diagnostic Platform - Product Status 34
Table 48: TR-LFIA Diagnostic Platform - Product Description 34
Table 49: bioMerieux S.A. Pipeline Products & Ongoing Clinical Trials Overview 35
Table 50: Magnotech System - Product Status 35
Table 51: Magnotech System - Product Description 35
Table 52: Biopico Systems Inc. Pipeline Products & Ongoing Clinical Trials Overview 36
Table 53: MONITOR System - Product Status 36
Table 54: MONITOR System - Product Description 36
Table 55: Boston University Pipeline Products & Ongoing Clinical Trials Overview 37
Table 56: Molecular Diagnostic Device - Sexually Transmitted Infections - Product Status 37
Table 57: Molecular Diagnostic Device - Sexually Transmitted Infections - Product Description 37
Table 58: Point-Of-Care Device - Allergen-Specific IgE - Product Status 38
Table 59: Point-Of-Care Device - Allergen-Specific IgE - Product Description 38
Table 60: CardioGenics Inc Pipeline Products & Ongoing Clinical Trials Overview 39
Table 61: QL Care Analyzer - Product Status 39
Table 62: QL Care Analyzer - Product Description 39
Table 63: Cepheid Pipeline Products & Ongoing Clinical Trials Overview 40
Table 64: GeneXpert Omni - Product Status 40
Table 65: GeneXpert Omni - Product Description 40
Table 66: GeneXpert Omni CLIA-Waived Point-of-Care System - Product Status 41
Table 67: GeneXpert Omni CLIA-Waived Point-of-Care System - Product Description 41
Table 68: Cepheid - Ongoing Clinical Trials Overview 42
Table 69: GeneXpert Omni - Xpert Omni Performance Evaluation for Linkage to Tuberculosis Care: The XPEL TB Trial 43
Table 70: ChipCare Corp Pipeline Products & Ongoing Clinical Trials Overview 44
Table 71: Polyvalent Analyzer (PAx) - Product Status 44
Table 72: Polyvalent Analyzer (PAx) - Product Description 44
Table 73: City, University of London Pipeline Products & Ongoing Clinical Trials Overview 45
Table 74: POC Device - Mood Disorders - Product Status 45
Table 75: POC Device - Mood Disorders - Product Description 45
Table 76: Co-Diagnostics HBDC, Inc. Pipeline Products & Ongoing Clinical Trials Overview 46
Table 77: LightPCR - Product Status 46
Table 78: LightPCR - Product Description 46
Table 79: Exosome Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 47
Table 80: Shahky - Product Status 47
Table 81: Shahky - Product Description 47
Table 82: Florida International University Pipeline Products & Ongoing Clinical Trials Overview 48
Table 83: Cortisol Detector - Product Status 48
Table 84: Cortisol Detector - Product Description 48
Table 85: Indian Institute of Technology Madras Pipeline Products & Ongoing Clinical Trials Overview 49
Table 86: Microfluidic Flow Analyzer - Product Status 49
Table 87: Microfluidic Flow Analyzer - Product Description 49
Table 88: Indiana University Pipeline Products & Ongoing Clinical Trials Overview 50
Table 89: Microfluidic Device - Cancer - Product Status 50
Table 90: Microfluidic Device - Cancer - Product Description 50
Table 91: Magna Diagnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview 51
Table 92: MAZER System - Product Status 51
Table 93: MAZER System - Product Description 51
Table 94: Maxygen-mobile DNA tests Pipeline Products & Ongoing Clinical Trials Overview 52
Table 95: Maxygen POC Device - Product Status 52
Table 96: Maxygen POC Device - Product Description 52
Table 97: mBio Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 53
Table 98: MBio CD4 System - Product Status 53
Table 99: MBio CD4 System - Product Description 53
Table 100: McKesson Corp Pipeline Products & Ongoing Clinical Trials Overview 54
Table 101: Proventys PDx System - Product Status 54
Table 102: Proventys PDx System - Product Description 54
Table 103: MML Ltd Pipeline Products & Ongoing Clinical Trials Overview 55
Table 104: MIDS Cardiac - Product Status 55
Table 105: MIDS Cardiac - Product Description 55
Table 106: Molbio Diagnostics Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 56
Table 107: Truelab Quattro Analyzer - Product Status 56
Table 108: Truelab Quattro Analyzer - Product Description 56
Table 109: Molecular Warehouse Ltd Pipeline Products & Ongoing Clinical Trials Overview 57
Table 110: Portable Biosensor Device - Product Status 57
Table 111: Portable Biosensor Device - Product Description 57
Table 112: Mologic Ltd Pipeline Products & Ongoing Clinical Trials Overview 58
Table 113: ACuTEGA - Product Status 58
Table 114: ACuTEGA - Product Description 58
Table 115: Nalia Systems Ltd Pipeline Products & Ongoing Clinical Trials Overview 59
Table 116: NALIA Single-Patient Point-Of-Care Device - Product Status 59
Table 117: NALIA Single-Patient Point-Of-Care Device - Product Description 59
Table 118: Newcastle University Pipeline Products & Ongoing Clinical Trials Overview 60
Table 119: SmartHEALTH POC System - Colorectal Cancer - Product Status 60
Table 120: SmartHEALTH POC System - Colorectal Cancer - Product Description 60
Table 121: Ohmx Corp Pipeline Products & Ongoing Clinical Trials Overview 61
Table 122: Handheld Clinical Analyzer - Product Status 61
Table 123: Handheld Clinical Analyzer - Product Description 61
Table 124: OncoGenesis Pipeline Products & Ongoing Clinical Trials Overview 62
Table 125: Genesis Point-Of-Care Diagnostic System - Product Status 62
Table 126: Genesis Point-Of-Care Diagnostic System - Product Description 62
Table 127: Pacific Nanoscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview 63
Table 128: Nanomonitor - Product Status 63
Table 129: Nanomonitor - Product Description 63
Table 130: Parallax Health Sciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 64
Table 131: SPARKS Mobile - Product Status 64
Table 132: SPARKS Mobile - Product Description 64
Table 133: Phoenix Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview 65
Table 134: Point of Care HIV Combo Device - Product Status 65
Table 135: Point of Care HIV Combo Device - Product Description 65
Table 136: POC Medical Systems Inc. Pipeline Products & Ongoing Clinical Trials Overview 66
Table 137: Pandora CDx Point-of-Care System - Product Status 66
Table 138: Pandora CDx Point-of-Care System - Product Description 66
Table 139: Pocared Diagnostics Ltd. Pipeline Products & Ongoing Clinical Trials Overview 67
Table 140: POCARED P-1000 - Product Status 67
Table 141: POCARED P-1000 - Product Description 67
Table 142: PositiveID Corp Pipeline Products & Ongoing Clinical Trials Overview 68
Table 143: Firefly Dx System - Product Status 68
Table 144: Firefly Dx System - Product Description 69
Table 145: Firefly Dx System - Zika Virus - Product Status 69
Table 146: Firefly Dx System - Zika Virus - Product Description 69
Table 147: Quanterix Corp Pipeline Products & Ongoing Clinical Trials Overview 70
Table 148: Simoa 5.0 - Product Status 70
Table 149: Simoa 5.0 - Product Description 70
Table 150: Radisens Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 71
Table 151: Radisens Instrument - Product Status 71
Table 152: Radisens Instrument - Product Description 71
Table 153: SenGenix Inc Pipeline Products & Ongoing Clinical Trials Overview 72
Table 154: SenGenix Strips And Reader System - Product Status 72
Table 155: SenGenix Strips And Reader System - Product Description 72
Table 156: Thermal Gradient Inc Pipeline Products & Ongoing Clinical Trials Overview 73
Table 157: FlashDirect-HC - Product Status 73
Table 158: FlashDirect-HC - Product Description 73
Table 159: FlashDirect-LC - Product Status 74
Table 160: FlashDirect-LC - Product Description 74
Table 161: Trinity Biotech Plc Pipeline Products & Ongoing Clinical Trials Overview 75
Table 162: Meritas Point of Care Analyzer - Product Status 75
Table 163: Meritas Point of Care Analyzer - Product Description 75
Table 164: Two Pore Guys Inc Pipeline Products & Ongoing Clinical Trials Overview 76
Table 165: Handheld Nanopore Based Device - Cancer - Product Status 76
Table 166: Handheld Nanopore Based Device - Cancer - Product Description 76
Table 167: University of California Berkeley Pipeline Products & Ongoing Clinical Trials Overview 77
Table 168: Microfluidic Blotting Device - Product Status 77
Table 169: Microfluidic Blotting Device - Product Description 77
Table 170: Mobile Molecular Diagnostics System - Product Status 78
Table 171: Mobile Molecular Diagnostics System - Product Description 78
Table 172: Multi-dimensional Microfluidic Device - Product Status 78
Table 173: Multi-dimensional Microfluidic Device - Product Description 78
Table 174: Point-Of-Care Microfluidic Device - Acute Promyelocytic Leukemia - Product Status 79
Table 175: Point-Of-Care Microfluidic Device - Acute Promyelocytic Leukemia - Product Description 79
Table 176: ViroCyt Inc Pipeline Products & Ongoing Clinical Trials Overview 80
Table 177: ViroTag EV71 - Product Status 80
Table 178: ViroTag EV71 - Product Description 80
Table 179: Wellstat Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 81
Table 180: Electrochemiluminescent Based RNA Detection Platform - Product Status 81
Table 181: Electrochemiluminescent Based RNA Detection Platform - Product Description 81
Table 182: Glossary 129

1.2 List of Figures
Figure 1: Point-of-Care (POC) Analyzers - Pipeline Products by Stage of Development 11
Figure 2: Point-of-Care (POC) Analyzers - Pipeline Products by Territory 12
Figure 3: Point-of-Care (POC) Analyzers - Pipeline Products by Regulatory Path 13
Figure 4: Point-of-Care (POC) Analyzers - Pipeline Products by Estimated Approval Date 14
Figure 5: Point-of-Care (POC) Analyzers - Ongoing Clinical Trials 15

【掲載企業】

Akers Biosciences Inc
Akonni Biosystems Inc
Alere Inc
Amplino B.V.
Analytical Diagnostic Solutions Inc
ApoCell Inc
Aquila Diagnostic Systems Inc.
Atonomics A/S
Attophotonics Biosciences GmbH
Beckman Coulter Inc
Binghamton University
Bio-Alternative Medical Devices Ltd
BioMedomics Inc
bioMerieux S.A.
Biopico Systems Inc.
Boston University
CardioGenics Inc
Cepheid
ChipCare Corp
City, University of London
Co-Diagnostics HBDC, Inc.
Exosome Diagnostics Inc
Florida International University
Indian Institute of Technology Madras
Indiana University
Magna Diagnostics GmbH
Maxygen-mobile DNA tests
mBio Diagnostics Inc
McKesson Corp
MML Ltd
Molbio Diagnostics Pvt. Ltd.
Molecular Warehouse Ltd
Mologic Ltd
Nalia Systems Ltd
Newcastle University
Ohmx Corp
OncoGenesis
Pacific Nanoscience, Inc.
Parallax Health Sciences, Inc.
Phoenix Biosystems Inc
POC Medical Systems Inc.
Pocared Diagnostics Ltd.
PositiveID Corp
Quanterix Corp
Radisens Diagnostics Ltd
SenGenix Inc
Thermal Gradient Inc
Trinity Biotech Plc
Two Pore Guys Inc
University of California Berkeley
ViroCyt Inc
Wellstat Diagnostics LLC

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ ポイント・オブ・ケア(POC)分析装置:医療機器パイプライン分析2017(Point-of-Care (POC) Analyzers - Medical Devices Pipeline Assessment, 2017)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆